Delaware can move ahead with a case calling out drug manufacturers for downplaying the addictive nature of opioids, the state's Superior Court ruled Monday, though it cut out claims against two major pharmacy chains as well as accusations of civil conspiracy.

The Delaware attorney general's office filed the suit in January 2018, accusing the drug companies of lying to prescribers and patients, encouraging ever-higher doses of painkillers and minimizing the risks of addiction and overdose, leading to higher health care, judicial, and social services costs to the state.

While the court allowed the negligence and consumer fraud case against the manufacturers and distributors to move forward, it dismissed similar claims against pharmacy chains, including Walgreens Boots Alliance Inc., as well as those facing civil conspiracy and creating a public nuisance claims.

The state's allegations that the pharmacy chains failed to identify red flags for abuse and report them to authorities were dismissed, since the attorney general's office hadn't submitted an affidavit of merit from an expert witness that state law requires of all health care negligence complaints, the order said. The state could refile those claims if it submitted the affidavit.

Walgreens is represented by Ballard Spahr attorneys Beth Moskow-Schnoll, William J. Burton, and Elizabeth A. Sloan.

Read the full article here. Subscription may be required.